Whole genome sequencing to help you improve your health and longevity. $999. U.S. price.
A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.
Screening test of 26 genes, including BRCA1 and BRCA2, for increased risk of developing breast, ovarian, and other inherited cancers.
Maternal blood-based non-invasive screening that predicts the presence of Down Syndrome (T21), Edwards Syndrome (T18), and Patau Syndrome (T13).
Saliva-based screening of prospective or currently pregnant parents to see if they carry inherited and rare conditions such as cystic fibrosis.
Comprehensive genetic screening of newborns for early childhood diseases.
Industry-leading genetic tests, whole genome sequencing, and interpretation for your patients.
Customized, fully integrated, research-only whole genome sequencing services.
Industry-leading genetic tests and genome sequencing solutions.
Hello! We are well aware of the media’s need to cover a wide range of subjects under very tight deadlines so we have pulled together the tools you may need to capture Veritas, quickly and accurately. If you would like to schedule an interview with one of our executives or have questions, please email us at
Veritas is The Genome Company. We screen the majority of an individual’s DNA through whole genome sequencing and interpretation to provide insights on inherited disease risks, carrier status, drug sensitivities, traits and ancestry. Our mission is to help people understand their genetics and make more informed health and lifestyle decisions with the involvement of their physician and access to skilled genetic counselors.
Company Overview PDF
The company was co-founded in 2014 by renowned Geneticist, George Church PhD, and leading scientists from the Personal Genome Project at Harvard Medical School and has grown to a team of more than 120 bioinformaticians, coders, clinicians, engineers and scientists.
Leadership Team PDF
Advisory Board PDF
PRODUCTS & SERVICES
Our flagship product is myGenome, which screens the majority of an individual’s DNA with whole genome sequencing and interpretation, including pharmacogenomics information. We also offer targeted testing services for inherited cancers and reproductive health screening tests as well as specialized services for
includes sequencing and interpretation of an individual’s whole genome to better guide decisions regarding medications, medical treatment, diet, and exercise.
is a key feature of myGenome and screens an individual’s genetic makeup to assess how effectively they would metabolize or potentially react to more than 200 drugs.
is a screening test to help understand one’s risk for hereditary breast and ovarian cancer risk.
is a multi-gene test to screen for hereditary breast and ovarian cancer risk.
is a routine, non-invasive screening test that provides reliable answers about a baby’s health.
Sometimes a bit of storytelling helps the science go down. That's why we teamed up with Emmy Award-winning filmmaker, Dina Rudick, to create a video series to help educate consumers on the basics of genetics. Our Cinema Veritas playlist will get you up to speed on the basics of DNA, whole genome sequencing and more.